This event will be held at the Brookings Institution and features CGD expert Amanda Glassman.
Private investment in health R&D by pharmaceutical companies, charitable foundations, and venture capital firms, among others, can help to save lives and boost the health of entire regions. But some countries’ health governance infrastructures, management capacities, regulatory processes, and policy conditions are better equipped to utilize this private funding than others. What governance factors promote an investment-friendly environment for the private sector? And how can countries attract more private sector health financing?
On March 30, Governance Studies at Brookings will host a panel of experts to discuss what conditions lead to good health governance and how those conditions affect a country’s ability to use private investments in health R&D. At the event, authors Darrell West and John Villasenor will release their new paper, “Health governance capacity: Enhancing private sector investment in global health,” which examines 18 countries throughout Asia and sub-Saharan Africa. How compatible is each country’s health governance strategy with effective use of private investment in R&D?"
Introduction
John Villasenor, Nonresident Senior Fellow, Governance Studies, Center for Technology Innovation, The Brookings Institution
Key Findings and Recommendations
Darrell West, Vice President and Director, Governance Studies; Founding Director, Center for Technology Innovation, The Brookings Institution
Panel discussion
John Villasenor, Nonresident Senior Fellow, Governance Studies, Center for Technology Innovation, The Brookings Institution
Loyce Pace, President & Executive Director, Global Health Council
Amanda Glassman, Chief Operating Officer and Senior Fellow, Center for Global Development
